Manufacturing and Production

Showing 15 posts of 5857 posts found.

vaccination-1215279_960_720

Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show

November 24, 2020 Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine

The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
fda_white_oak_building_web_0

FDA approves Oxlumo for treating primary hyperoxaluria type 1

November 24, 2020 Manufacturing and Production

The FDA has approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1).  This rare genetic condition …

OPEN Health reveals new CEO appointment

November 19, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health

Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …

AstraZeneca’s Brilinta reduces stroke and death risk in head and neck artery atherosclerosis patients

November 17, 2020 Manufacturing and Production

AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had …
dr_reddys_chairman_satish

Pfizer takes legal action against Indian drugmakers over generic cancer drug

November 17, 2020 Manufacturing and Production

Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges …
shutterstock_159488225

Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn

November 17, 2020 Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …
pfizer_finland_hq_february_13_2009

Pfizer launches pilot delivery programme for its coronavirus vaccine

November 17, 2020 Manufacturing and Production

Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be …
moderna_norwood_plant

UK secures 5m doses of Moderna’s vaccine after it shows 94.5% interim efficacy

November 17, 2020 Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, UK, Vaccine

US firm Moderna has swooped in with Phase 3 interim data for its own messenger RNA (mRNA) vaccine candidate, mRNA-1273, …
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020 Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020 Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
nice_reception_2

NICE recommends venetoclax combo, a non-chemo option for untreated chronic lymphocytic leukaemia

November 10, 2020 Manufacturing and Production, Sales and Marketing AbbVie, NHS, NICE, UK, leukaemia, venetoclax

NICE has recommended venetoclax in combination with obinutuzumab under final draft guidance for the first-line treatment of untreated chronic lymphocytic …
stethoscope_and_background_doctor

Scottish Medicines Consortium greenlights Nubeqa for prostate cancer

November 10, 2020 Manufacturing and Production, Sales and Marketing

The Scottish Medicines Consortium has approved Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) who are …
unnamed_1

FDA grants Emergency Use Authorization to Eli Lilly’s antibody drug to treat COVID-19

November 10, 2020 Manufacturing and Production

The FDA has granted Emergency Use Authorization (EUA) to Eli Lilly’s antibody drug bamlanivimab for the treatment of COVID-19 patients …
flu_vaccination_grippe_5115654021

Sinovac COVID-19 trial suspended in Brazil due to severe adverse event

November 10, 2020 Manufacturing and Production Brazil, COVID, COVID Vaccine, coronavirus

Brazil’s health regulator Anvisa has suspended a clinical trial for China’s Sinovac coronavirus vaccine due to the occurrence of a …
astrazeneca_sign_sky

Argentina secures 22 million COVID-19 vaccine doses from AstraZeneca and Oxford Uni

November 9, 2020 Manufacturing and Production, Sales and Marketing Argentina, AstraZeneca, COVID-19, Vaccine

AstraZeneca has committed to an agreement to deliver 22 million doses of its COVID-19 vaccine candidate, co-developed in partnership with …
The Gateway to Local Adoption Series

Latest content